SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-05-09
👔
Edwards Lifesciences Corp
@EW_InsiderForm 4 Filing: LORANGER STEVEN R Acquires (Grant) shares of $EW
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Edwards Lifesciences Corp
Ticker: $EW
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-05-08
Shares: 4,315
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, LORANGER STEVEN R, holds the title of Director at Edwards Lifesciences Corp.
On 2026-05-08, the insider transacted 4,315 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
LORANGER STEVEN R (Director) was granted $0 of $EW
Post-Transaction Position: 7,933 shares
SEC Accession No: 0001225208-26-005053 (CIK: 1226924)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.